BioNTech SE

US$87.51As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BNTXHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR 26.64%
Div yield —
ROE (8.14%)
Biotechnology
Beta (5Y) 1.33
PE TTM —
TSR TTM (15.78%)
Mkt cap US$21.70B
ROIC (29.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$98
12.28%
(48.51%)
Hold 12|9|12|8|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
1.94
1.95
2.17
2.39
(0.19%)
3.30%
11.14%
25.02%
Revenue€B
1.318
1.381
1.439
1.508
9.38%
12.46%
11.94%
18.45%
Peers (US$21.70B)
Cap (US$)
PE
72.62B
27.30x
2.114B
13.71x
Capital
TTM
5Y
10Y
Leveragex
0.066
0.323
0.255
EBIT/Intx
2.110
0.520
0.506
Own earn%
(23.92)
8.88
16.82
Sh yield%
43.27
34.85
31.79
Owners
Insiders/Inst%
8.01
57.05
Short interest%
2.88
SBC / revenue%
2.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
12–22
$1 testx
0.0
Incr. ROIC%
1